Joji Tani

4.7k total citations · 1 hit paper
125 papers, 1.7k citations indexed

About

Joji Tani is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Joji Tani has authored 125 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Hepatology, 44 papers in Epidemiology and 31 papers in Molecular Biology. Recurrent topics in Joji Tani's work include Liver Disease Diagnosis and Treatment (36 papers), Hepatocellular Carcinoma Treatment and Prognosis (27 papers) and MicroRNA in disease regulation (17 papers). Joji Tani is often cited by papers focused on Liver Disease Diagnosis and Treatment (36 papers), Hepatocellular Carcinoma Treatment and Prognosis (27 papers) and MicroRNA in disease regulation (17 papers). Joji Tani collaborates with scholars based in Japan, United States and Somalia. Joji Tani's co-authors include Tsutomu Masaki, Asahiro Morishita, Kyoko Oura, Koji Fujita, Tomoko Tadokoro, Takashi Himoto, Hisaaki Miyoshi, Hirohito Yoneyama, Hisakazu Iwama and Takako Nomura and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Joji Tani

111 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review

2021 295 citations Kyoko Oura, Asahiro Morishita et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joji Tani Japan	21	712	457	434	418	407	125	1.7k
Akira Mitoro Japan	24	703 1.0×	360 0.8×	352 0.8×	392 0.9×	429 1.1×	103	1.9k
Kyoko Oura Japan	19	513 0.7×	411 0.9×	249 0.6×	306 0.7×	305 0.7×	72	1.2k
Genshu Wang China	18	669 0.9×	530 1.2×	338 0.8×	318 0.8×	297 0.7×	74	1.6k
Sunhwa Kim South Korea	5	547 0.8×	359 0.8×	417 1.0×	380 0.9×	489 1.2×	10	1.5k
D. Lee Gorden United States	24	623 0.9×	300 0.7×	538 1.2×	291 0.7×	312 0.8×	38	1.9k
Yinying Lu China	24	620 0.9×	298 0.7×	432 1.0×	656 1.6×	474 1.2×	99	1.8k
Tomoyuki Nagai Japan	24	599 0.8×	260 0.6×	528 1.2×	310 0.7×	266 0.7×	95	1.7k
Takemi Akahane Japan	24	565 0.8×	232 0.5×	260 0.6×	529 1.3×	766 1.9×	108	1.8k
Sara Vander Borght Belgium	23	452 0.6×	282 0.6×	604 1.4×	656 1.6×	452 1.1×	50	1.8k
Silvia Affò United States	16	673 0.9×	387 0.8×	382 0.9×	997 2.4×	998 2.5×	24	2.3k

Countries citing papers authored by Joji Tani

Since Specialization

Citations

This map shows the geographic impact of Joji Tani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joji Tani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joji Tani more than expected).

Fields of papers citing papers by Joji Tani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joji Tani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joji Tani. The network helps show where Joji Tani may publish in the future.

Co-authorship network of co-authors of Joji Tani

This figure shows the co-authorship network connecting the top 25 collaborators of Joji Tani. A scholar is included among the top collaborators of Joji Tani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joji Tani. Joji Tani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tadokoro, Tomoko, Kyoko Oura, M. Nakahara, et al.. (2025). Genetic Polymorphisms of ALDH2 and ADH1B in Alcohol-Induced Liver Injury: Molecular Mechanisms of Inflammation and Disease Progression in East Asian Populations. International Journal of Molecular Sciences. 26(17). 8328–8328. 1 indexed citations

Mimura, Shima, Asahiro Morishita, Kyoko Oura, et al.. (2025). Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging Targets. Journal of Clinical Medicine. 14(23). 8503–8503.

Mimura, Shima, Asahiro Morishita, Kyoko Oura, et al.. (2025). Galectins and Liver Diseases. International Journal of Molecular Sciences. 26(2). 790–790. 2 indexed citations

Tadokoro, Tomoko, Hung Tai, Kei Takuma, et al.. (2025). Do Patients With Alcoholic Cirrhosis Accurately Recognize Their Alcohol Tolerance? A Study Comparing Self‐Perception and ALDH2/ADH1B Genotype. Hepatology Research. 56(3). 322–329.

Tadokoro, Tomoko, Miwa Kawanaka, Kazuhiro Takahashi, et al.. (2025). A Noninvasive Method of Diagnosing Metabolic Dysfunction-Associated Steatohepatitis Using Cytokeratin-18 Fragment and FIB-3 Index. Diagnostics. 15(8). 1023–1023.

Arai, Taeang, Masanori Atsukawa, Akihito Tsubota, et al.. (2024). Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction‐associated steatotic liver disease: A prospective, multicentre, observational study. Diabetes Obesity and Metabolism. 26(11). 4958–4965. 15 indexed citations

Tani, Joji, et al.. (2024). Extrahepatic Cancer Risk in Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antivirals. Microorganisms. 12(9). 1926–1926. 3 indexed citations

Oura, Kyoko, Asahiro Morishita, Tomoko Tadokoro, et al.. (2024). Immune Microenvironment and the Effect of Vascular Endothelial Growth Factor Inhibition in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 25(24). 13590–13590. 8 indexed citations

Tadokoro, Tomoko, Joji Tani, Asahiro Morishita, et al.. (2024). The Treatment of Hepatocellular Carcinoma with Major Vascular Invasion. Cancers. 16(14). 2534–2534. 6 indexed citations

10.

Tomonari, Tetsu, Joji Tani, Yasushi Sato, et al.. (2023). Clinical Features and Outcomes of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma. Cancers. 15(21). 5221–5221. 14 indexed citations

11.

Morishita, Asahiro, Kyoko Oura, Tomoko Tadokoro, et al.. (2023). Galectin-9 in Gastroenterological Cancer. International Journal of Molecular Sciences. 24(7). 6174–6174. 12 indexed citations

12.

Oura, Kyoko, Asahiro Morishita, Kei Takuma, et al.. (2023). Efficacy and outcome of molecular targeted therapies in elderly patients with hepatocellular carcinoma: Relative dose intensity associated with overall survival. Cancer Medicine. 12(24). 22023–22037. 2 indexed citations

13.

Ogawa, Chikara, Kei Takuma, M. Nakahara, et al.. (2023). Usefulness of the Measurement of Psoas Muscle Volume for Sarcopenia Diagnosis in Patients with Liver Disease. Diagnostics. 13(7). 1245–1245. 10 indexed citations

14.

Morishita, Asahiro, Kyoko Oura, Tomoko Tadokoro, et al.. (2023). MicroRNAs and Nonalcoholic Steatohepatitis: A Review. International Journal of Molecular Sciences. 24(19). 14482–14482. 9 indexed citations

15.

Kobayashi, Nobuya, Hideki Kobara, Noriko Nishiyama, et al.. (2021). Wafer paper and ring-mounted polyglycolic acid sheet method for shielding artificial gastric floor. Minimally Invasive Therapy & Allied Technologies. 31(4). 548–555. 4 indexed citations

16.

Kobara, Hideki, Nobuya Kobayashi, Noriko Nishiyama, et al.. (2021). Long-term outcomes of over-the-scope clip for refractory gastrointestinal diseases. Minimally Invasive Therapy & Allied Technologies. 31(4). 628–634. 5 indexed citations

17.

Shi, Tingting, Hisakazu Iwama, Koji Fujita, et al.. (2021). Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences. 22(23). 13071–13071. 27 indexed citations

18.

Nishiyama, Noriko, Hideki Kobara, Maki Ayaki, et al.. (2021). White Spot, a Novel Endoscopic Finding, May Be Associated with Acid-Suppressing Agents and Hypergastrinemia. Journal of Clinical Medicine. 10(12). 2625–2625. 4 indexed citations

19.

Morishita, Asahiro, Koji Fujita, Hisakazu Iwama, et al.. (2020). Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma. American Journal of Physiology-Gastrointestinal and Liver Physiology. 318(3). G401–G409. 29 indexed citations

20.

Kato, Kiyohito, Jian Gong, Hisakazu Iwama, et al.. (2012). The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In Vivo. Molecular Cancer Therapeutics. 11(3). 549–560. 198 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact